PCR array results comparing CD44high vs CD44low OSCC cell populations using SCC4 and SCC9 cells revealed a greater than 6-fold increase in GLI3 expression in the CD44high cancer stem cell subtype [159]. This evidence concerns the gene GLI3 and cancer.